Kymera Share Price
NASDAQ: KYMR | Large Cap | HealthcareKymera Stock Performance
Kymera Share Price Today
As of 19 November 2026, Kymera Therapeutics, Inc.'s share price is $121.21. The stock opened at $122.19, compared to its previous close of $121.33. During today's trading session, Kymera Therapeutics, Inc.'s share price traded between $120.16 and $123.52, with an average price of $121.84. Over the past 52 weeks, the stock has recorded a high of $142.41 and a low of $63.21. In terms of performance, Kymera Therapeutics, Inc.'s share price has risen by 48.82% over the last six months and is up 78.54% on a year-on-year basis.
Kymera Share Price Chart
Kymera Quarterly Profit & Loss
All figures in USD
Kymera Annual Profit & Loss
All figures in USD
Kymera Balance Sheet
All figures in USD Million
Kymera Cash Flow
All figures in USD Million
About Kymera
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
Kymera Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $127.47 | $121.03 | -4.46% |
Oct 2026 | $111.47 | $126.69 | +12.96% |
Sep 2026 | $117.02 | $112.15 | -6.64% |
Aug 2026 | $100.86 | $120.13 | +16.28% |
Jul 2026 | $114.11 | $103.31 | -9.96% |
Jun 2026 | $80.66 | $114.74 | +40.88% |
May 2026 | $80.78 | $81.44 | +0.46% |
Apr 2026 | $84.45 | $81.07 | -2.68% |
Mar 2026 | $90.05 | $83.31 | -8.84% |
Feb 2026 | $71.60 | $91.38 | +25.71% |
Jan 2026 | $77.83 | $72.69 | -6.48% |
Dec 2025 | $66.75 | $77.73 | +14.49% |